Vera Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Vera Therapeutics Total Assets Growth & History (VERA)
Vera Therapeutics's total assets was $734.7M for fiscal 2025.
View full Vera Therapeutics company overviewVera Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $734.7M | $79.1M | +12.06% |
| 2024 | 2024-12-31 | $655.7M | $480.1M | +273.51% |
| 2023 | 2023-12-31 | $175.5M | $44.1M | +33.56% |
| 2022 | 2022-12-31 | $131.4M | $47.7M | +56.94% |
| 2021 | 2021-12-31 | $83.7M | $29.2M | +53.51% |
| 2020 | 2020-12-31 | $54.6M | — | — |
Vera Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $533.0M | −$45.5M | −7.87% |
| Q1 2026 | 2026-03-31 | $621.7M | $11.6M | +1.90% |
| Q4 2025 | 2025-12-31 | $734.7M | $79.1M | +12.06% |
| Q3 2025 | 2025-09-30 | $517.5M | $148.9M | +40.41% |
| Q2 2025 | 2025-06-30 | $578.5M | $181.2M | +45.62% |
| Q1 2025 | 2025-03-31 | $610.2M | $190.8M | +45.50% |
| Q4 2024 | 2024-12-31 | $655.7M | $480.1M | +273.51% |
| Q3 2024 | 2024-09-30 | $368.6M | $192.9M | +109.86% |
| Q2 2024 | 2024-06-30 | $397.3M | $202.1M | +103.55% |
| Q1 2024 | 2024-03-31 | $419.4M | $209.8M | +100.07% |
| Q4 2023 | 2023-12-31 | $175.5M | $44.1M | +33.56% |
| Q3 2023 | 2023-09-30 | $175.6M | $44.2M | +33.68% |
| Q2 2023 | 2023-06-30 | $195.2M | $46.4M | +31.18% |
| Q1 2023 | 2023-03-31 | $209.6M | $44.6M | +27.05% |
| Q4 2022 | 2022-12-31 | $131.4M | $47.7M | +56.94% |
| Q3 2022 | 2022-09-30 | $131.4M | $40.2M | +44.10% |
| Q2 2022 | 2022-06-30 | $148.8M | $51.1M | +52.37% |
| Q1 2022 | 2022-03-31 | $165.0M | $113.1M | +218.33% |
| Q4 2021 | 2021-12-31 | $83.7M | $29.2M | +53.51% |
| Q3 2021 | 2021-09-30 | $91.2M | — | — |
| Q2 2021 | 2021-06-30 | $97.6M | — | — |
| Q1 2021 | 2021-03-31 | $51.8M | — | — |
| Q4 2020 | 2020-12-31 | $54.6M | — | — |
Vera Therapeutics total assets trends
Over the last five fiscal years, Vera Therapeutics's total assets increased from $54.6M to $734.7M, a change of $680.2M. The latest reported quarter, Q2 2026, shows $533.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vera Therapeutics source filings ↗